Please login to the form below

Not currently logged in
Email:
Password:

Mysimba

This page shows the latest Mysimba news and features for those working in and with pharma, biotech and healthcare.

Positive data in Saxenda diabetes prevention study

Positive data in Saxenda diabetes prevention study

None of these has made significant headway since their US launches, and of the three only Orexigen's drug (branded as  Mysimba) has been backed in Europe, with both Belviq and

Latest news

  • CHMP thumbs up for Novo's obesity drug Saxenda CHMP thumbs up for Novo's obesity drug Saxenda

    s drug under the Mysimba brand name last December. ... The latest development means European doctors could have three drugs at their disposal to manage obesity patients in the coming months, with Saxenda and Mysimba slotting into the market alongside

  • Orexigen’s obesity pill Mysimba set for European approval Orexigen’s obesity pill Mysimba set for European approval

    The CHMP has recommended a marketing authorisation for Mysimba (naltrexone/bupropion) for weight management of overweight or obese adults. ... Across these studies, more patients treated with Mysimba achieved clinically-relevant weight loss than patients

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics